A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Recruiting

Phase 1

Phase 2

BI 3812465A Study in People With Diabetic Macular Edema to Test How Well Different Doses of BI 3812465 Are Tolerated

Sponsor:

Boehringer Ingelheim

Code:

NCT07553429

Conditions

Diabetic Macular Edema

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Low dose BI 3812465

Medium dose BI 3812465

High dose BI 3812465

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-06-25. This information was provided to ClinicalTrials.gov by Boehringer Ingelheim on 2026-06-23.